2022 American Transplant Congress
High Level Cytomegalovirus Viremia in Liver Transplant Recipients: Risk Factors and Associated Outcomes
*Purpose: To evaluate epidemiology, risk-factors and outcomes of high-level CMV viremia in LTX recipients.*Methods: Retrospective review of adults who received LTX between 1/1/2017-9/30/2020. Inclusion criteria…2022 American Transplant Congress
Sustained Alloantigen Exposure Reinforces Transplantation Tolerance
*Purpose: While advances have been made in therapies that achieve tolerance in mouse transplant models, successful tolerance is still vulnerable to inflammatory challenges that can…2022 American Transplant Congress
Early Retrieval of the Right Kidney for Combined Heart and Kidney Transplantation is Feasible and Reduces Costs
*Purpose: Combined heart and kidney transplants (cHKT) have increased in recent years. Standard procurement practice often necessitates kidney extraction and packaging after the heart team…2022 American Transplant Congress
End-to-Side Splenic to Hepatic Artery Reconstruction in Liver Transplant: A Case Series
Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT
*Purpose: Optimal hepatic artery (HA) blood flow post-liver transplantation (LT) is necessary for long-term allograft success. HA thrombosis (HAT) contributes to significant morbidity and mortality…2022 American Transplant Congress
Outcomes of Transplants in Kidneys with Multiple Arteries
The Royal London Hospital, London, United Kingdom
*Purpose: Variations in kidney anatomy, such as the presence of multiple arteries, may affect decisions regarding implantation. A significant proportion of living donor and some…2022 American Transplant Congress
Palliative Care for the Patients with Failing Kidney Allograft: Kraft Survey
*Purpose: Care of patients with failing kidney allograft can be challenging with discordant expectations between clinicians and patients. These patients often suffer from multiple morbidities,…2022 American Transplant Congress
Impact of Dysgeusia on Transplant Recipients with Refractory Cytomegalovirus with/without Resistance Receiving Maribavir: Post-Hoc Analyses from a Phase 3 Randomized Trial
*Purpose: In a Phase 3 study (SOLSTICE; NCT02931539), maribavir (MBV) was superior to investigator-assigned therapies (IAT; val/ganciclovir, foscarnet, or cidofovir) for CMV clearance at Wk…2022 American Transplant Congress
International Practices on COVID-19 Vaccine Mandates for Transplant Candidates
*Purpose: The coronavirus disease 2019 (COVID-19) pandemic has created unprecedented challenges and there are practice differences for solid organ transplant programs worldwide. We sought to…2022 American Transplant Congress
Pretransplant microRNAs in Liver Perfusate Associate with Early Allograft Dysfunction
University of Maryland School of Medicine, Baltimore, MD
*Purpose: Early allograft dysfunction (EAD) in liver transplantation (LT) is associated with poor long-term graft and patient survival. Prior to LT, while organs are stored…2022 American Transplant Congress
Tuberculosis Screening Test Predicting Tuberculosis Infection in Solid Organ Transplant Recipients a Retrospective Cohort Study
*Purpose: Tuberculosis (TB) is a common infection that affects patients after solid organ transplantation (SOT). Thus, the American Society of transplantation (AST) recommends screening all…
- « Previous Page
- 1
- …
- 77
- 78
- 79
- 80
- 81
- …
- 190
- Next Page »